Outsourced Pharma Capacity Update Videos - Large Molecule

  1. Northway Biotech Capacity Update April 2025: Large Molecule Development 4/22/2025

    Detra Glinatsis, Vice President of Business Development, presents the advanced capabilities, strategic growth, and expanding capacity of Northway Biotech, a global biologics CDMO.

  2. Abzena Capacity Update April 2025: Large Molecule Development 4/22/2025

    See first-hand how AbZelectPRO™, an evolved approach to cell line development, can simplify selection, enhance stability, and de-risk your program for faster regulatory approval.

  3. Curia Capacity Update April 2025: Large Molecule Development 4/22/2025

    Site head Bill Hermans showcases our facility's specialized capabilities in Hopkinton, Massachusetts, and shares how our team serves as a true scientific partner to clients.

  4. Cytovance Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Speed up your program with end-to-end microbial and mammalian biologics development and manufacturing expertise — spanning everything from biosimilars to vaccines.

  5. Novartis Capacity Update April 2025: Large Molecule Development 4/22/2025

    Experience a global network of expertise and proven manufacturing capabilities that can help accelerate your clinical and commercial drug substance programs.

  6. Samsung Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Leveraging advanced technology, expertise, and flexible capacity, clients can reduce development time and costs while ensuring a smooth transition from clinical to commercial manufacturing.

  7. Boehringer Ingelheim Capacity Update April 2025: Large Molecule Development 4/22/2025

    Explore how world-class contract manufacturing expertise and global capabilities can help accelerate your biologic from development to commercial success.

  8. Leveraging Advanced Technology And Proven Expertise 4/22/2025

    By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.

  9. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Large Molecule Development 4/22/2025

    Associate Director kojoX and Technology Development, Rasmus Petersen, presents a high-level overview of FDB’s capabilities, its global facilities network, and capacity updates for BIOLOGICS.

  10. Cytovance Capacity Update July 2024: Large Molecule Development 9/18/2024

    Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.